"COVID-19 Vaccination and Pulmonary Embolism" by Cara Gose, Kaylee Dixon et al.
  •  
  •  
 

Author Credentials

Andrea Bodine, MD: Associate Clinical Professor at University of New England, Department of Obstetrics and Gynecology

Kaylee Dixon, 4th year medical student at University of New England

Cara Gose, 4th year medical student at University of New England

Author ORCID Identifier

0000-0002-9879-8174

Abstract

Background: The incidence of pulmonary embolism (PE) has increased since the outbreak of the COVID-19 pandemic and may be due to the observed hypercoagulable state. There is conflicting evidence that thromboembolism risk increases after vaccination and that vaccines decrease the probability of having a thromboembolic event. This study aimed to explore how vaccination status impacts occurrence of PE after a positive COVID-19 test. The hypothesis was that vaccinated, immunocompetent patients have a lower incidence of PE after COVID-19 compared to unvaccinated patients.

Methods: This was a retrospective chart review at a teaching hospital in New England from 1/01/2021 to 3/31/2023 to identify the impact of vaccination status on the incidence of PEs after a positive COVID-19 test in immunocompetent patients. IRB exclusion was obtained. Subjects aged 12 to 80 years old who had PEs within 6 months of testing positive for COVID-19 were included; excluded were outside the age range, without documentation of PE and COVID-19 within 6 months, had orthopedic surgery within three months, chest trauma, thrombophilias, or immunodeficiency; received vector vaccine; and had multiple visits for a PE. Subjects were separated into vaccinated and unvaccinated groups. Charts were reviewed for age, sex, race, documented PE and positive COVID-19 test within 6 months, brand and number of vaccines, and exclusion criteria. Statistics used t-test with p-value 0.05.

Results: Fifty subjects were coded for PE and COVID-19; 23 were excluded, leaving 27 subjects. Ages ranged from 12 to 80 years, with a mean of 63.8. Nineteen were male, 8 female; 23 white and 4 non-white. There were 12 unvaccinated, 15 vaccinated; T-value 1.37, p=0.183. There was no significant difference between development of a PE within six months of a positive COVID-19 test result regardless of vaccination status, which failed to reject the null hypothesis. These results were limited by small sample size.

Discussion: This study found no correlation between vaccination status and PE within 6 months of COVID-19, which neither confirmed nor negated prior studies regarding the relationship between vaccines, PEs, and COVID-19. Further studies may serve to clarify the relationship.

Creative Commons License

Creative Commons Attribution-NonCommercial 4.0 International License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Share

COinS